13.80 USD
↗ 0.39 (2.90%)AT CLOSE (03:59 PM EDT)
Jade Biosciences, Inc. Common Stock
JBIONASDAQ • USD
13.79
↘ 0.01 (0.07%)
POST MARKET (AS OF 04:04 PM EDT)
Post Market
AS OF 04:04 PM EDT
13.79
↘ 0.01 (0.07%)
Market: OPEN
Jade Biosciences, Inc. Common Stock (JBIO) trades at $13.79 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest JBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 6, 2026.
Open?$13.19
High?$14.13
Low?$13.18
Prev. Close?$13.41
Volume?788.6K
Avg. Volume?904.6K
VWAP?$13.79
Rel. Volume?0.87x
Bid / Ask
Bid?$13.85 × 100
Ask?$13.89 × 100
Spread?$0.04
Midpoint?$13.87
Valuation & Ratios
Market Cap?852.8M
Shares Out?63.6M
Float?41.4M
Float %?83.9%
P/E Ratio?N/A
P/B Ratio?1.94
EPS?-$1.93
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Themes
Employees
55
Market Cap
852.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-04-29
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: (781) 312-3013
WALTHAM, MA 02453
Phone: (781) 312-3013
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?25
Piotroski F-Score?0/9Weak
Altman Z-Score?15.11Safe
Confidence?38%Very Low
Short InterestSqueeze Risk
Short % of Float?26.55%Squeeze Risk
Short Interest?11.0M
Days to Cover?11.8
Free Float41.4M
Avg Daily Volume934.0K
Settlement Date2026-09-15
Financial Health
Current Ratio?14.93Strong
Quick Ratio?14.93Strong
Cash Ratio?3.40Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.94CHEAP▾
Peers100
S&P75
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-28.0%WEAK▾
S&P6
ROA?-26.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-110213000
Enterprise Value?$745.6M
Fundamentals ratios updated end of day